Diabetic peripheral neuropathy (DPN) is a leading cause of lower-limb amputation, which significantly diminishes life expectancy and quality of life (Selvarajah et al., 2019)
Its relatively limited sample size may have underpowered our comparative analyses
The class action complaint pointed to a lack of clinical data that supports the notion that simply boosting the amount of naturally occurring GLP-1 in the body has sustained weight-loss effects. In the era of GLP-1 agonist medications, what can supplement companies say about products that claim to support the drugs
Be cautious if you have cancer
Ozempic influences insulin and metabolism, thus impacting estrogen and progesterone levels.
The once-weekly injector, known as Mounjaro KwikPen, now covers doses ranging from 2.5 mg to 15 mg, according to a Reuters report